Authors' response to the letter by Dr. Eisa-Beygi

J Neurol Sci. 2016 Oct 15:369:392. doi: 10.1016/j.jns.2016.06.057. Epub 2016 Jun 28.
No abstract available

Publication types

  • Letter

MeSH terms

  • Hemangioma, Cavernous, Central Nervous System / prevention & control*
  • Hemorrhage / drug therapy
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Simvastatin / therapeutic use*

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Simvastatin